Vera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q4 2024.
  • Vera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $3.37M, a 14.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $3.37M +$423K +14.3% Dec 31, 2024 10-K 2025-02-28
Q3 2024 $3.92M +$440K +12.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.93M -$2.1M -52.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.43M -$2.16M -47.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.95M -$2.22M -43% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $3.48M -$2.29M -39.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.03M -$1.69M -29.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.59M -$1.68M -26.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.17M +$5.17M Dec 31, 2022 10-K 2024-03-27
Q3 2022 $5.77M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $5.72M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $6.28M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.